In this interview with Ventures Accelerated Life Science, Avacta CEO @coughlin582 shares how Avacta is redefining precision oncology with its tumor-targeted delivery platform, and why this matters for patients, clinicians, and partners. https://t.co/XwKZyOpOPN #AVCT